Literature DB >> 9032413

Statistical analysis of highly skewed immune response data.

D McGuinness1, S Bennett, E Riley.   

Abstract

This paper considers methods of statistical analysis for highly skewed immune response data. Observations from population studies of immunological variables are rarely normally distributed between individuals; typically the distribution shows extreme levels of skewness. In some situations, skewness remains considerable even after transforming the data. Using resampling techniques, applied to several actual datasets of ELISA assay data, we consider the robustness of normal parametric methods, e.g. t tests and linear regression. Despite the skewness of the transformed data, we demonstrate that such methods are quite robust depending on the number of observations, type of analysis and severity of skewness. We also illustrate how bootstrap resampling can be used to provide a valid alternative method of analysis that can be used either for checking normal parametric analysis or as a direct method of analysis. We illustrate this combined approach by analysing real data to test for association between human serum antibodies to malaria merozoite surface proteins, MSP1 and MSP2, and resistance to clinical malaria, and confirm the protective effect of antibodies to MSP1 and demonstrated a similar protective effect for some antibodies to MSP2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032413     DOI: 10.1016/s0022-1759(96)00216-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  18 in total

1.  Sample size calculations in studies using the EuroQol 5D.

Authors:  M Roset; X Badia; N E Mayo
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

2.  Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.

Authors:  N Ahlborg; D Haddad; A B Siddique; C Roussilhon; C Rogier; J F Trape; M Troye-Blomberg; K Berzins
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

3.  Impact of anthelminthic treatment in pregnancy and childhood on immunisations, infections and eczema in childhood: a randomised controlled trial.

Authors:  Juliet Ndibazza; Harriet Mpairwe; Emily L Webb; Patrice A Mawa; Margaret Nampijja; Lawrence Muhangi; Macklyn Kihembo; Swaib A Lule; Diana Rutebarika; Barbara Apule; Florence Akello; Hellen Akurut; Gloria Oduru; Peter Naniima; Dennison Kizito; Moses Kizza; Robert Kizindo; Robert Tweyongere; Katherine J Alcock; Moses Muwanga; Alison M Elliott
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

4.  Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation.

Authors:  Alison M Elliott; Patrice A Mawa; Emily L Webb; Margaret Nampijja; Nancy Lyadda; Joseph Bukusuba; Moses Kizza; Proscovia B Namujju; Juliet Nabulime; Juliet Ndibazza; Moses Muwanga; James A G Whitworth
Journal:  Vaccine       Date:  2010-10-30       Impact factor: 3.641

5.  Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial.

Authors:  Emily L Webb; Patrice A Mawa; Juliet Ndibazza; Dennison Kizito; Alice Namatovu; Jacqueline Kyosiimire-Lugemwa; Bridget Nanteza; Margaret Nampijja; Lawrence Muhangi; Patrick W Woodburn; Hellen Akurut; Harriet Mpairwe; Miriam Akello; Nancy Lyadda; Joseph Bukusuba; Macklyn Kihembo; Moses Kizza; Robert Kizindo; Juliet Nabulime; Christine Ameke; Proscovia B Namujju; Robert Tweyongyere; Moses Muwanga; James A G Whitworth; Alison M Elliott
Journal:  Lancet       Date:  2010-12-20       Impact factor: 79.321

6.  The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda.

Authors:  Elizabeth J Anderson; Emily L Webb; Patrice A Mawa; Moses Kizza; Nancy Lyadda; Margaret Nampijja; Alison M Elliott
Journal:  Vaccine       Date:  2012-01-31       Impact factor: 3.641

7.  Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.

Authors:  Swaib Abubaker Lule; Patrice A Mawa; Gyaviira Nkurunungi; Margaret Nampijja; Dennison Kizito; Florence Akello; Lawrence Muhangi; Alison M Elliott; Emily L Webb
Journal:  Vaccine       Date:  2014-12-19       Impact factor: 3.641

8.  Relationship between quality of care and choice of clinical computing system: retrospective analysis of family practice performance under the UK's quality and outcomes framework.

Authors:  Evangelos Kontopantelis; Iain Buchan; David Reeves; Kath Checkland; Tim Doran
Journal:  BMJ Open       Date:  2013-08-02       Impact factor: 2.692

Review 9.  A guide to modern statistical analysis of immunological data.

Authors:  Bernd Genser; Philip J Cooper; Maria Yazdanbakhsh; Mauricio L Barreto; Laura C Rodrigues
Journal:  BMC Immunol       Date:  2007-10-26       Impact factor: 3.615

10.  Stage-specific immune responses in human Necator americanus infection.

Authors:  S M Geiger; I R Caldas; B E Mc Glone; A C Campi-Azevedo; L M De Oliveira; S Brooker; D Diemert; R Corrêa-Oliveira; J M Bethony
Journal:  Parasite Immunol       Date:  2007-07       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.